Tag: clinical trials
-
Precision Meds Shown Effective in Rare Cancer
Results from a clinical trial show patients with rare bile duct tumors respond to an experimental treatment blocking a specific cancer-causing protein.
-
Trial to Assess Multi-Factor Blood Test for Cancer
A clinical trial is set to begin that evaluates genomic and related data from routine blood tests to screen for cancer in real-world settings.
-
Trial to Test Smart Watch to Guide Blood Thinners
A clinical trial is planned to test heart rhythms measured with an Apple smart watch to guide use of blood thinning medicines in people with irregular heartbeat.
-
Infant Gut Microbiome Biomarker Study Underway
A clinical study has begun analyzing infants’ stool samples to determine the characteristics of healthy microbial communities in young children.
-
Alzheimer’s Assn Collecting Real-World Therapy Data
An advocacy group for Alzheimer’s disease care and research is establishing a network for collecting long-term safety and outcomes data from patients in real-world settings.
-
Trial Okayed for Engineered Cell Cancer Therapy
A clinical trial is set to begin testing engineered immune-system cells designed to precisely target and infiltrate cancerous tumors without other potentially toxic proteins.
-
Trial Shows Oral Covid-19 Vaccine Produces Antibodies
A clinical trial shows a Covid-19 vaccine taken as a tablet produces protective antibodies in nasal membranes that in some cases last for up to a year.
-
Synthetic Bio Microbiome Biotech Gains $15M in Seed Funds
A developer of therapies produced with synthetic biology for diseases linked to microbes in the gut is raising $15 million in seed financing.
-
Trial Begins of Precise Gene Editing for Heart Disease
A clinical trial is underway evaluating a precise form of Crispr gene editing as a one-time therapy for an inherited form of heart disease.
-
Cancer Nutrition Therapy Biotech Raises $47M in Early Funds
A start-up company developing nutritional therapies to attack precise molecular cancer targets is raising $47 million in its first venture funding round.